Posted in | News | Nanobusiness

Nanotech Security Closes $3.9 Million Private Placement

Nanotech Security Corp. (the “Company”), developer of next-generation security and authentication features using patented nano-optics, confirms that it has now closed its recently announced $3.9 million private placement of 4,900,500 subscription receipts.

Each subscription receipt is convertible into a unit consisting of one common share and one half of one common share purchase warrant with each whole warrant exercisable for a period of 18 months at a price of $0.90. All securities issued in connection with the placement are subject to a hold period expiring on December 21, 2013. The proceeds from the placement are being held in escrow pending the completion of two patent-entity acquisitions, which were previously announced.

Nanotech CEO Doug Blakeway commented, “Once the financing proceeds are released from escrow, we will use them to accelerate development and commercialization of our nanotechnology based optical imaging products for use in anti-counterfeiting systems for currency, documents and branded commercial products. We were pleased by the tremendous interest we received from the financial community which sees the opportunities for us to revolutionize the anti-counterfeiting and brand protection marketplace.”

Mr. Blakeway added, “”In addition to eliminating a significant royalty on product sales, the patent entity acquisitions will provide Nanotech with flexibility to develop applications for our nano-optic technology beyond security and anti-counterfeiting. Once the purchase is complete, we will have direct ownership of the principal nanotechnology patents, as well as additional related intellectual property, giving us increased IP breadth and security of title.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.